Insulin Regular (Human Recombinant)
Insulin Regular (Human Recombinant) is a short-acting human insulin. It helps cells in the body absorb glucose from the blood, thereby lowering blood sugar levels. It is typically administered subcutaneously approximately 30 minutes before a meal, and can also be administered intravenously under medical supervision.
Dosage by Body Weight
Dosing must be highly individualized based on the patient's metabolic needs, blood glucose monitoring results, and glycemic control goals. Standard daily insulin requirements vary, typically ranging between 0.5 and 1 unit/kg/day. Always consult an endocrinologist or qualified healthcare provider for precise dosing.
- Body Weight
- Below 5 kg
- Dose
- Highly individualized
- Frequency
- As directed by a physician
- Tracking Notes
- Requires strict neonatal or pediatric endocrinology supervision. High risk of hypoglycemia. Doses are typically calculated in fractions of a unit.
- Body Weight
- 5-7 kg
- Dose
- Highly individualized
- Frequency
- Typically administered 30 minutes before meals
- Tracking Notes
- Dose must be tailored to specific carbohydrate intake and pre-meal blood glucose levels. Continuous monitoring is essential.
- Body Weight
- 8-10 kg
- Dose
- Highly individualized
- Frequency
- Typically administered 30 minutes before meals
- Tracking Notes
- Requires careful calculation based on daily insulin requirements and insulin sensitivity factor.
- Body Weight
- 11-15 kg
- Dose
- Highly individualized
- Frequency
- Typically administered 30 minutes before meals
- Tracking Notes
- Dosing adjustment may be needed during illness, physical activity, or changes in meal patterns.
- Body Weight
- 16-20 kg
- Dose
- Highly individualized
- Frequency
- Typically administered 30 minutes before meals
- Tracking Notes
- Ensure proper injection technique (subcutaneous rotation of sites) to prevent lipodystrophy.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Highly individualized | As directed by a physician | Requires strict neonatal or pediatric endocrinology supervision. High risk of hypoglycemia. Doses are typically calculated in fractions of a unit. |
| 5-7 kg | Highly individualized | Typically administered 30 minutes before meals | Dose must be tailored to specific carbohydrate intake and pre-meal blood glucose levels. Continuous monitoring is essential. |
| 8-10 kg | Highly individualized | Typically administered 30 minutes before meals | Requires careful calculation based on daily insulin requirements and insulin sensitivity factor. |
| 11-15 kg | Highly individualized | Typically administered 30 minutes before meals | Dosing adjustment may be needed during illness, physical activity, or changes in meal patterns. |
| 16-20 kg | Highly individualized | Typically administered 30 minutes before meals | Ensure proper injection technique (subcutaneous rotation of sites) to prevent lipodystrophy. |
Formulation
Purpose
Used to improve glycemic control in adults and pediatric patients with Type 1 and Type 2 diabetes mellitus.
Generic Name
Insulin Regular (Human Recombinant)Branded Drug Names
Insulin Regular (Human Recombinant) is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.